P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
6,149.35
61.45 (1.01%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 26.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,037.52
1,010.37
27.15
2.69%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,037.52
1,010.37
27.15
2.69%
Raw Material Cost
222.14
617.53
-395.39
-64.03%
Purchase of Finished goods
48.27
0.00
48.27
(Increase) / Decrease In Stocks
1.80
2.89
-1.09
-37.72%
Employee Cost
171.70
160.12
11.58
7.23%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
272.54
144.15
128.39
89.07%
Total Expenditure (Excl Depreciation)
716.45
924.69
-208.24
-22.52%
Operating Profit (PBDIT) excl Other Income
321.07
85.68
235.39
274.73%
Other Income
13.34
85.23
-71.89
-84.35%
Operating Profit (PBDIT)
334.41
170.91
163.50
95.66%
Interest
0.34
7.45
-7.11
-95.44%
Exceptional Items
0.00
-3.81
3.81
100.00%
Gross Profit (PBDT)
334.07
159.65
174.42
109.25%
Depreciation
17.42
33.09
-15.67
-47.36%
Profit Before Tax
316.65
126.58
190.07
150.16%
Tax
84.34
30.13
54.21
179.92%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
232.31
96.44
135.87
140.89%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
232.31
96.44
135.87
140.89%
Equity Capital
16.60
30.62
-14.02
-45.79%
Face Value
10.00
2.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
30.95%
8.48%
0.00
22.47%
Gross Profit Margin
32.20%
15.80%
0.00
16.40%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 1,037.52 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 14.38% vs 4.57% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 232.31 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 22.26% vs 3.15% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 321.07 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.37% vs 10.85% in Dec 2024

Nine Monthly - Interest
Interest 0.34 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -32.00% vs -3.85% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.95%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024